glp-1 for hs RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions[v1] GLP-1 and GIP: Magic bullet

Sep 2020;8(5):1184-1193

Common Topical Application Patterns Use case Facial anti-aging (community use) Concentration 1-2% Frequency Once or twice daily Cycle length 8-12 weeks Use case Scalp / hair-research interest Concentration 1-3% Frequency Daily Cycle length 12+ weeks ongoing Use case Compounded post-procedure Concentration 1-2% Frequency Per clinician guidance Cycle length Per clinician guidance Topical concentrations are typically expressed as percent weight

the freeze-drying process comprises the following steps, preparing a liquid and filling at the temperature of 20-30 , putting a sample into a freeze dryer, quickly reducing the temperature of a plate layer to-40 , preserving heat for 1h, when the temperature of a clapboard is-10 +/-2 , preserving heat for 1h, quickly reducing the temperature of the plate layer to-40 within 1h, preserving heat for 4h, transferring to a cold trap at-50 , vacuumizing to below 10Pa, firstly reducing the temperature of the plate layer to-5 , preserving heat for 2h, then heating the plate layer to 10 within 3h, when a product is at 0 , starting to increase the temperature of the plate layer to 40 , and when the product is increased to 30 , preserving heat for 5 h

10.3389/fnut.2021.797513 77

Briefly, the initial small increase of SHs stimulates GH secretion in the early phase of puberty, whereas during late puberty, the further increase of SHs determines bone ossification and, therefore, the arrest of growth [18]

It's generally well-tolerated, but should be used under guidance especially injectable forms